17105
Our previous work , built on the early pioneering multikinase inhibitor LY294002 , resulted in the only PI3K vascular - targeted PI3K inhibitor prodrug , SF1126 , which has now completed Phase I clinical trials .
 Chemical: LY294002; Chemical: SF1126
Please list all entity words in the text that fit the category.Output format is "type1: word1; type2: word2". 
Option: Chemical 
Text: {0} 
Answer:
 Chemical: LY294002; Chemical: SF1126